HEDIMED (Human Exposomic Determinants of Immune Mediated Diseases) is a Horizon 2020 RIA initiative coordinated by Tampere University (2020-2024).

The responsibility of Nature-Based Solutions Research Group is to characterize the microbiota of the child’s living environment including home indoor environment and outdoor environment, to characterize the presence of toxicants in child’s living environment, and to characterize the connections between environmental toxicants and commensal microbiota. The HEDIMED has 20 partners. The project also includes a supplementary trial of the PREVALL intervention.